Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Natural protease inhibitors may enhance chemotherapeutic efficacy

Nov. 8, 2004

Novel TGF-beta receptor type II kinase inhibitors claimed by Pfizer

Nov. 8, 2004

New inhibitors of PDE4, MMP and/or TNF-alpha discovered at Celgene

Nov. 8, 2004

New anticancer and immunostimulant agent isolated from plants by Japanese team

Nov. 8, 2004

Femara approved for post-tamoxifen treatment of early breast cancer

Nov. 5, 2004

ChemGenex plans phase II study of Quinamed in prostate cancer

Nov. 5, 2004

Second stage of CoFactor phase II study given green light

Nov. 5, 2004

MediGene concludes license agreement for cancer-killing herpes simplex viruses

Nov. 5, 2004

Velcade designated fast track drug for relapsed & refractory mantle cell lymphoma

Nov. 5, 2004

KI-105, a novel HSGAG-mimetic compound

Nov. 5, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.